Lassen Therapeutics

Lassen Therapeutics is a clinical-stage biotech company focused on developing novel antibody therapeutics to treat serious diseases with high unmet needs. Their lead program, LASN01, is a first-in-class monoclonal antibody targeting the IL-11 receptor (IL-11R). IL-11 is a key mediator of fibrosis, making LASN01 a promising treatment for fibro-inflammatory diseases like thyroid eye disease (TED) and idiopathic pulmonary fibrosis (IPF). Lassen also has a second program, LASN500, which targets IL-18 binding protein (IL-18BP) for the potential treatment of cancer.

Lassen's team is comprised of experienced drug developers with a strong track record of bringing antibody therapeutics to market. They are committed to combining innovative science, leading technology, and unmatched know-how to create life-improving medicines. Driven by a passion to improve the lives of patients, Lassen Therapeutics continues to advance its pipeline of promising antibody therapies.

Lassen Therapeutics offers a hybrid work culture, allowing employees to work both onsite and remotely. The company offers unlimited time off, a competitive benefits package, and a 401(k) plan with matching contributions.

Lassen Therapeutics offers a comprehensive benefits package for employees and their families including medical, dental, vision and life insurance. They also provide a 401(k) plan with a matching contribution, stock equity, unlimited time off, and other benefits.

Lassen Therapeutics is a clinical-stage biotech company focused on developing novel, best-in-class antibody therapies to improve the lives of patients suffering from serious diseases. They target compelling new targets that are central to diseases with significant unmet needs, such as fibro-inflammatory diseases including thyroid eye disease (TED), and cancer. Their lead program, LASN01, is a first-in-class monoclonal antibody targeting IL-11 receptor (IL-11R), which plays a critical role in the pathogenesis of inflammatory fibrosis.

Lassen Therapeutics fosters a collaborative and innovative culture built on honesty, respect, and a shared passion for creating life-improving medicines. They value adaptation in the face of challenges, transparent communication, and a focus on people, including their team, collaborators, and patients. This emphasis on people is reflected in their competitive benefits package, which includes medical, dental, vision, and life insurance, as well as a 401(k) plan with a matching contribution, stock equity, and unlimited time off.

Lassen Therapeutics is committed to creating an inclusive work environment where all employees feel valued, respected, and empowered. They are an equal opportunity employer and actively seek to recruit and retain a diverse workforce, ensuring that all qualified applicants receive consideration for employment without regard to race, color, religion, gender, gender identity, national origin, genetics, disability, age, sexual orientation, veteran status, or any other protected categories. Lassen's values of honesty, collaboration, and respect for all are woven into their efforts to foster a culture of diversity, equity, and inclusion.